A randomised placebo-controlled trial in the management of ostheoarthritis of the temporomandibular joint for arthrocentesis with additional dexamethasone versus arthrocentesis alone.
- Conditions
- joint painostheoarthritis10005944
- Registration Number
- NL-OMON30205
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Initial therapy not succesful; splint-therapy, soft food diet, NSAID's, physiotherapy .
Local anesthetics gives pain relief.
Exclusion Criteria
Ankylosis
Rheumatoid arthritis
Underwent open jaw surgery in the past
Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pain.<br /><br><br /><br>The difference in pain before and after the treatment will be measured using<br /><br>the Visual Analog Scale (0 100 mm).<br /><br><br /><br>In the experimental group the treatment is considered succesful when 90 percent<br /><br>of the patiënts achieve a 30 percent reduction in pain with jaw movement on the<br /><br>VAS scale .<br /><br>In the control group the treatment is considered succesful when 50 percent of<br /><br>the patiënts achieve a 30 percent reduction in pain with jaw movement on the<br /><br>VAS scale.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Mandibular Function Impairment Questionnaire (MFIQ).<br /><br>Difference in units before and after the treatment on the MFIQ scale.<br /><br>The treatment is considered succesfull if there is a minimum reduction of 13<br /><br>units on the MFIQ scale.<br /><br><br /><br>The maximum mouth opening (mm) is measured at each folluw up.</p><br>